#2017585
Meatalacsail agus meatalacsail-M
Metalaxyl and metalaxyl-M
Meatalacsail agus meatalacsail-M
Metalaxyl and metalaxyl-M
Meatalacsail agus meatalacsail-M
Metalaxyl and metalaxyl-M
Meatalacsail agus meatalacsail-M
Metalaxyl and metalaxyl-M
Meatalacsail agus meatalacsail-M
Metalaxyl and metalaxyl-M
MEATALACSAIL-M
METALAXYL-M
MEATALACSAIL
METALAXYL
Meatalacsail-M
Metalaxyl-M
Le Rialachán Cur Chun Feidhme (AE) 2017/2069 ón gCoimisiún cuirtear síneadh le tréimhse formheasa na substainte gníomhaí meatalacsail go dtí an 30 Meitheamh 2023, agus cuirtear síneadh le tréimhse formheasa na substainte gníomhaí peanocsulam go dtí an 31 Iúil 2023.
Commission Implementing Regulation (EU) 2017/2069 extends the approval period of the active substance metalaxyl until 30 June 2023, and of the active substance penoxsulam until 31 July 2023.
sa séú colún, dul in éag an fhormheasa, de ró 304, Meatalacsail, cuirtear “30 Meán Fómhair 2026” in ionad an dáta;
in the sixth column, expiration of approval, of row 304, Metalaxyl, the date is replaced by ‘30 September 2026’;
Treoir 2002/64/CE ón gCoimisiún an 15 Iúil 2002 lena leasaítear Treoir 91/414/CEE ón gComhairle chun cineadón-eitil, ciahalafop-búitil, famocsadón, florasulam, meatalacsail-M agus picilinifein a áireamh mar shubstaintí gníomhacha (IO L 189, 18.7.2002, lch. 31).
Commission Directive 2002/64/EC of 15 July 2002 amending Council Directive 91/414/EEC to include cinidon-ethyl, cyhalofop butyl, famoxadone, florasulam, metalaxyl-M and picolinafen as active substances (OJ L 189, 18.7.2002, p. 31).
Rialachán (AE) 2016/486 ón gCoimisiún an 29 Márta 2016 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar chiasófaimíde, chioglocsaidime, aigéid dhéfhluaraicéitigh, feanocsacarb, fluimeitriline, fluaipicilíde, fluipiridhéfhúróin, flocsaipiorocsaid, chreasocsaim-meitile, mhandastróibine, mheapainipirime, mheatalacsail-M, pheindémheatailine agus teafluitrine i dtáirgí áirithe nó ar tháirgí áirithe (IO L 90, 6.4.2016, lch. 1).
Commission Regulation (EU) 2016/486 of 29 March 2016 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for cyazofamid, cycloxydim, difluoroacetic acid, fenoxycarb, flumetralin, fluopicolide, flupyradifurone, fluxapyroxad, kresoxim-methyl, mandestrobin, mepanipyrim, metalaxyl-M, pendimethalin and tefluthrin in or on certain products (OJ L 90, 6.4.2016, p. 1).
Rialachán Cur Chun Feidhme (AE) 2017/2069 ón gCoimisiún an 13 Samhain 2017 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha floiniocaimíd (IKI-220), meatalacsail, peanocsulam agus prócuineaisíd (IO L 295, 14.11.2017, lch. 51).
Commission Implementing Regulation (EU) 2017/2069 of 13 November 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances flonicamid (IKI-220), metalaxyl, penoxsulam and proquinazid (OJ L 295, 14.11.2017, p. 51).
Rialachán (AE) 441/2012 ón gCoimisiún an 24 Bealtaine 2012 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh défheineasáite, défheintrine, boscailide, cadúsafos, clórantrainileapróil, clóratailinile, clóitiainídine, ciopróconasóil, deiltemheitrine, díceamba, défeanaconasóil, déineacap, eatocsasóil, feinpiorocsamáite, fluibeindé-aimíde, fluidhé-ocsainile, gliofosáite, meatalacsaile-M, meiptildéineacap, nóvalúrón, tiaimeatocsam agus trí-asafos i dtáirgí áirithe nó ar tháirgí áirithe (IO L 135, 25.5.2012, lch. 4).
Commission Regulation (EU) No 441/2012 of 24 May 2012 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for bifenazate, bifenthrin, boscalid, cadusafos, chlorantraniliprole, chlorothalonil, clothianidin, cyproconazole, deltamethrin, dicamba, difenoconazole, dinocap, etoxazole, fenpyroximate, flubendiamide, fludioxonil, glyphosate, metalaxyl-M, meptyldinocap, novaluron, thiamethoxam, and triazophos in or on certain products (OJ L 135, 25.5.2012, p. 4).
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237
Maidir leis na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, feanasacuin, fluaipicilíd, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, paclabútrasól, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237, níl an measúnú riosca a rinne na Ballstáit is rapóirtéirí lena mbaineann de bhun Airteagal 11 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 tugtha chun críche go fóill.
For the active substances aclonifen, ametoctradin, beflubutamid, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, fenazaquin, fluopicolide, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, paclobutrazol, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.
Rialachán Cur Chun Feidhme (AE) 2017/2069 ón gCoimisiún an 13 Samhain 2017 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha floiniocaimíd (IKI-220), meatalacsail, peanocsulam agus prócuineaisid (IO L 295, 14.11.2017, lch. 51).
Commission Implementing Regulation (EU) 2017/2069 of 13 November 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances flonicamid (IKI-220), metalaxyl, penoxsulam and proquinazid (OJ L 295, 14.11.2017, p. 51).
Rialachán Cur Chun Feidhme (AE) 2017/2069 ón gCoimisiún an 13 Samhain 2017 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha floiniocaimíd (IKI-220), meatalacsail, peanocsulam agus prócuineaisíd (IO L 295, 14.11.2017, lch. 51).
Commission Implementing Regulation (EU) 2017/2069 of 13 November 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances flonicamid (IKI-220), metalaxyl, penoxsulam and proquinazid (OJ L 295, 14.11.2017, p. 51).
Rialachán Cur Chun Feidhme (AE) 2023/918 ón gCoimisiún an 4 Bealtaine 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, víreas polaihéadróise núicléach Helicoverpa armigera, himeacsasól, aigéad iondóiliolbútarach, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, feinmeideafam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, víreas polaihéadróise núicléach Spodoptera littoralis, Trichoderma asperellum tréithchineál T34 agus Trichoderma atroviride tréithchineál I-1237 (IO L 119, 5.5.2023, lch. 160).
Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (OJ L 119, 5.5.2023, p. 160).
Rialachán Cur Chun Feidhme (AE) 2023/918 ón gCoimisiún an 4 Bealtaine 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aclóinífein, aigéad iondóiliolbútarach, aimeatochtraidin, beaflubútaimid, beintiavalacarb, boscailid, captan, cleataidim, cioglocsaidim, ciafluaimeitifein, dasaimeit, déchlófop, démheatomorf, eiteafón, feanasacuin, feinmeideafam, fluaipicilíd, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, himeacsasól, mandaprópaimid, meatalacsail, meataildéad, meatam, meatasaclór, meitríbhúisin, milbimeictin, paclabútrasól, peanocsulam, pirimeafos-meitil, própamacarb, prócuineaisid, próitiaconasól, S-meitileaclór, Trichoderma asperellum tréithchineál T34, Trichoderma atroviride tréithchineál I-1237, víreas polaihéadróise núicléach Helicoverpa armigera agus víreas polaihéadróise núicléach Spodoptera littoralis, (IO L 119, 5.5.2023, lch. 160).
Commission Implementing Regulation (EU) 2023/918 of 4 May 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aclonifen, ametoctradin, beflubutamid, benthiavalicarb, boscalid, captan, clethodim, cycloxydim, cyflumetofen, dazomet, diclofop, dimethomorph, ethephon, fenazaquin, fluopicolide, fluoxastrobin, flurochloridone, folpet, formetanate, Helicoverpa armigera nucleopolyhedrovirus, hymexazol, indolylbutyric acid, mandipropamid, metalaxyl, metaldehyde, metam, metazachlor, metribuzin, milbemectin, paclobutrazol, penoxsulam, phenmedipham, pirimiphos-methyl, propamocarb, proquinazid, prothioconazole, S-metolachlor, Spodoptera littoralis nucleopolyhedrovirus, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237 (OJ L 119, 5.5.2023, p. 160).
Rialachán Cur Chun Feidhme (AE) 2020/617 ón gCoimisiún an 5 Bealtaine 2020 lena ndéantar an formheas ar an tsubstaint ghníomhach meatalacsail-M a athnuachan, agus lena gcuirtear srian ar úsáid síolta a chóireáiltear le táirgí cosanta plandaí ina bhfuil meatalacsail-M, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2020/617 of 5 May 2020 renewing the approval of the active substance metalaxyl-M, and restricting the use of seeds treated with plant protection products containing it, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 is to be incorporated into the EEA Agreement.
32020 R 0617: Rialachán Cur Chun Feidhme (AE) 2020/617 ón gCoimisiún an 5 Bealtaine 2020 lena ndéantar an formheas ar an tsubstaint ghníomhach meatalacsail-M a athnuachan, agus lena gcuirtear srian ar úsáid síolta a chóireáiltear le táirgí cosanta plandaí ina bhfuil meatalacsail-M, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún (IO L 143, 6.5.2020, lch. 6).
32020 R 0617: Commission Implementing Regulation (EU) 2020/617 of 5 May 2020 renewing the approval of the active substance metalaxyl-M, and restricting the use of seeds treated with plant protection products containing it, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 143, 6.5.2020, p. 6).
Rialachán (AE) 2017/171 ón gCoimisiún an 30 Eanáir 2017 lena leasaítear Iarscríbhinní II III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhair le haghaidh aimínipirilide, ciofluifeanaimíde, ciopróconasóil, dé-eatofeancarb, déthiacarbamáite, fluasafop-P, fluaipioraim, halocsafop, isifeitimíde, meatalacsail, próiheicseaidé-óin, própacuiseafoip, pirimeiteanaile, Trichoderma atroviride tréithchineál SC1 agus socsaimíde i dtáirgí áirithe nó ar tháirgí áirithe (IO L 30, 3.2.2017, lch. 45).
Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products (OJ L 30, 3.2.2017, p. 45).